Print

Medicamento de Patentes - UNOPS/MX/SO/0031-2020
Details
Locations:Mexico
Start Date:Jan, 2021
End Date:Unknown
Contract value: USD 2,697,348
Sectors: Health
Categories:Goods
Funding Agencies:
Date posted:Mar 23, 2021
Description
Reference: UNOPS/MX/SO/0031-2020
Description: Medicamento de Patentes
Clave 010.000.6171.00: Lenvatinib.
Clave 010.000.6172.00: Lenvatinib.

